Psychiatric Adverse Effects of Levetiracetam in Malignant Glioma Populations; a Retrospective Cohort Study

Objective: Levetiracetam is commonly used in malignant glioma populations because of its efficacy, limited drug-drug interactions and adverse effects. Although, there has been growing evidence of adverse neuropsychiatric side effects from levetiracetam; however, such evidence in malignant brain tumo...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Paul Thisayakorn, Isabel Schuermeyer
Formato: article
Lenguaje:EN
Publicado: Prince of Songkla University 2021
Materias:
R
Acceso en línea:https://doaj.org/article/2719ee7b09eb47e882fdd9822721fa80
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!